| NASDAQ (usa) |
 |
6715.56 | -12.11 | -0.18% |
| FTSE 100 (london) |
|
7487.96 | -5.12 | -0.07% |
| DAX (german) |
 |
13465.51 | 235.94 | 1.78% |
| NIKKEI 225 (japan) |
|
22420.08 | 408.47 | 1.86% |
| Hang - Seng (hong kong) |
|
28594.06 | 348.52 | 1.23% |
| NIFTY - 50 (india) | ||||
| Straits Times (singapore) |
|
3391.61 | 17.53 | 0.52% |
| KOSPI (korea) |
|
2556.47 | 33.04 | 1.31% |
| All Ordinaries (australia) |
|
6005.30 | 28.90 | 0.48% |
| BOVESPA (brazil) |
|
74092.76 | -215.73 | -0.29% |
GlaxoSmithKline plc (MX: GSKN)
GSKN Technical Analysis
5
| As on 14th Nov 2025 GSKN STOCK Price closed @ 864.00 and we RECOMMEND Strong Buy for LONG-TERM with Stoploss of 72.52 & Strong Buy for SHORT-TERM with Stoploss of 307.22 we also expect STOCK to react on Following IMPORTANT LEVELS. |
GSKNSTOCK Price
| Open | 864.00 | Change | Price | % |
| High | 864.00 | 1 Day | -1.71 | -0.20 |
| Low | 864.00 | 1 Week | 114.00 | 15.20 |
| Close | 864.00 | 1 Month | 196.50 | 29.44 |
| Volume | 73 | 1 Year | 196.50 | 29.44 |
| 52 Week High 865.71 | 52 Week Low 667.50 | ||||
MX Mexico Most Active Stocks
| AMXL | 19.28 | -0.36% |
| PV | 8.50 | 7.32% |
| CEMEXCPO | 20.04 | 1.93% |
| GMEXICOB | 167.32 | 0.70% |
| FR | 621.63 | 0.72% |
| WALMEX | 58.81 | -0.29% |
| GFNORTEO | 169.12 | -3.39% |
| ALFAA | 15.82 | 2.06% |
| GENTERA | 44.34 | -1.05% |
| NEMAKA | 3.99 | -1.97% |
MX Mexico Top Gainers Stocks
MX Mexico Top Losers Stocks
| GSKN Daily Charts |
GSKN Intraday Charts |
Whats New @ Bazaartrend |
GSKN Free Analysis |
|
|
GSKN Important Levels Intraday
| RESISTANCE | 864.00 |
| RESISTANCE | 864.00 |
| RESISTANCE | 864.00 |
| RESISTANCE | 864.00 |
| RESISTANCE | 864.00 |
| RESISTANCE | 864.00 |
| RESISTANCE | 864.00 |
| RESISTANCE | 864.00 |
GSKN Forecast December 2025
| 4th UP Forecast | 1246.8 |
| 3rd UP Forecast | 1124.03 |
| 2nd UP Forecast | 1048.15 |
| 1st UP Forecast | 972.26 |
| 1st DOWN Forecast | 755.74 |
| 2nd DOWN Forecast | 679.85 |
| 3rd DOWN Forecast | 603.97 |
| 4th DOWN Forecast | 481.2 |
GSKN Weekly Forecast
| 4th UP Forecast | 1126.07 |
| 3rd UP Forecast | 1042.02 |
| 2nd UP Forecast | 990.07 |
| 1st UP Forecast | 938.12 |
| 1st DOWN Forecast | 789.88 |
| 2nd DOWN Forecast | 737.93 |
| 3rd DOWN Forecast | 685.98 |
| 4th DOWN Forecast | 601.93 |
GSKN Forecast2025
| 4th UP Forecast | 1246.8 |
| 3rd UP Forecast | 1124.03 |
| 2nd UP Forecast | 1048.15 |
| 1st UP Forecast | 972.26 |
| 1st DOWN Forecast | 755.74 |
| 2nd DOWN Forecast | 679.85 |
| 3rd DOWN Forecast | 603.97 |
| 4th DOWN Forecast | 481.2 |
GlaxoSmithKline plc ( MX Mexico Symbol : GSKN )
Sector : Healthcare And Other Stocks in Same Sector
Sector : Healthcare And Other Stocks in Same Sector
GSKN Business Profile
GlaxoSmithKline plc, together with its subsidiaries, engages in the creation, discovery, development, manufacture, and marketing of pharmaceutical products, vaccines, over-the-counter medicines, and health-related consumer products in the United Kingdom, the United States, and internationally. It operates through four segments: Pharmaceuticals, Pharmaceuticals R&D, Vaccines, and Consumer Healthcare. The company offers pharmaceutical products comprising medicines in the therapeutic areas, such as respiratory, HIV, immuno-inflammation, oncology, anti-viral, central nervous system, cardiovascular and urogenital, metabolic, anti-bacterial, and dermatology. It also provides consumer healthcare products in wellness, oral health, nutrition, and skin health categories. The company offers its consumer healthcare products in the form of nasal sprays, tablets, syrups, lozenges, gum and trans-dermal patches, caplets, infant syrup drops, liquid filled suspension, wipes, gels, effervescents, toothpastes, toothbrushes, mouthwashes, denture adhesives and cleansers, topical creams and non-medicated patches, lip balm, gummies, and soft chews. It has collaboration agreements with 23andMe; Lyell Immunopharma, Inc.; Novartis; Sanofi SA; Surface Oncology; Progentec Diagnostics, Inc.; Alector, Inc.; and CureVac AG., as well as strategic partnership with IDEAYA Biosciences, Inc. and Vir Biotechnology, Inc. GlaxoSmithKline plc was founded in 1715 and is headquartered in Brentford, the United Kingdom. Address: 980 Great West Road, Brentford, United Kingdom, TW8 9GS
© 2005-2023 BazaarTrend.com All rights reserved.
Data and information is provided for informational purposes only, and is not intended for trading purposes.
Neither BazaarTrend.com website nor any of its promoters shall be liable for any errors
or delays in the content, or for any actions taken in reliance thereon. Your use of this website constitutes
acceptance of our Terms Of Service
Data and information is provided for informational purposes only, and is not intended for trading purposes.
Neither BazaarTrend.com website nor any of its promoters shall be liable for any errors
or delays in the content, or for any actions taken in reliance thereon. Your use of this website constitutes
acceptance of our Terms Of Service